These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 12017222)
1. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes". Banerji MA J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222 [TBL] [Abstract][Full Text] [Related]
2. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus. Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582 [TBL] [Abstract][Full Text] [Related]
3. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335 [TBL] [Abstract][Full Text] [Related]
4. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. Osei K; Schuster DP Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385 [TBL] [Abstract][Full Text] [Related]
5. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance. Taha D; Umpaichitra V; Banerji MA; Castells S J Pediatr Endocrinol Metab; 2006 Feb; 19(2):135-42. PubMed ID: 16562586 [TBL] [Abstract][Full Text] [Related]
7. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. Umpaichitra V; Bastian W; Taha D; Banerji MA; AvRuskin TW; Castells S J Clin Endocrinol Metab; 2001 Apr; 86(4):1605-9. PubMed ID: 11297591 [TBL] [Abstract][Full Text] [Related]
8. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
9. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. Elder DA; Prigeon RL; Wadwa RP; Dolan LM; D'Alessio DA J Clin Endocrinol Metab; 2006 Jan; 91(1):185-91. PubMed ID: 16263830 [TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. Osei K; Gaillard T; Schuster D Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222 [TBL] [Abstract][Full Text] [Related]
11. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Osei K; Gaillard T; Schuster DP Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394 [TBL] [Abstract][Full Text] [Related]
12. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity. Umpaichitra V; Banerji MA; Castells S J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in type 2 diabetic youth. Mizokami-Stout K; Cree-Green M; Nadeau KJ Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):255-62. PubMed ID: 22732484 [TBL] [Abstract][Full Text] [Related]
14. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Umpierrez GE; Clark WS; Steen MT Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964 [TBL] [Abstract][Full Text] [Related]
15. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. Elder DA; Woo JG; D'Alessio DA Pediatr Diabetes; 2010 Aug; 11(5):314-21. PubMed ID: 19961550 [TBL] [Abstract][Full Text] [Related]
16. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus. Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824 [TBL] [Abstract][Full Text] [Related]
17. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T; Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481 [TBL] [Abstract][Full Text] [Related]
18. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests. Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997 [TBL] [Abstract][Full Text] [Related]
19. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. RISE Consortium Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506 [TBL] [Abstract][Full Text] [Related]
20. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]